Naltrexone Accord (Naltrexone Hydrochloride)

Naltrexone Hydrochloride acts as a competitive antagonist at the mu (μ) opioid receptors. By binding without activating these receptors, it blocks the euphoric and reinforcing signals produced by alcohol and opioid substances, thereby diminishing cravings and the risk of relapse.

The specific dose and dosing schedule of Naltrexone Accord are determined by the prescribing healthcare professional based on the patient’s clinical condition, response to therapy, and any relevant medical considerations.

Safety data for Naltrexone Accord in pregnancy and lactation are limited. Healthcare providers should evaluate the potential benefits against possible risks and discuss these considerations with the patient before initiating therapy.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Naltrexone Accord shares the same mechanism of action as other oral opioid antagonists such as naloxone, but it is formulated for chronic oral use rather than acute emergency reversal. Its long‑acting profile makes it suitable for maintenance therapy in alcohol and opioid dependence.

Store Naltrexone Accord at temperatures below 25 °C in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain its stability and potency.

Naltrexone Accord is taken orally, usually with water. The exact timing (e.g., with or without food) and frequency are determined by the prescribing clinician based on individual treatment goals.

Serious risks include potential liver injury, severe depression, suicidal thoughts, and allergic reactions such as anaphylaxis. Patients should be monitored regularly for signs of hepatic dysfunction and mood changes, and any severe adverse events should prompt immediate medical attention.

Naltrexone Accord is contraindicated in individuals with acute hepatitis, severe liver impairment, or those currently using opioid analgesics or dependent on opioids without prior detoxification, as it may precipitate withdrawal. Consultation with a healthcare professional is essential before starting therapy.